American Association for the Advancement of Science, Science Translational Medicine, 430(10), 2018
DOI: 10.1126/scitranslmed.aao2731
Full text: Unavailable
CSPG4 is frequently expressed in glioblastoma and presents a viable target for CAR-T cell treatment.